### üöÄ AI in Healthcare - Viz.ai Webinar

This article announces a webinar showcasing how Viz.ai One‚Ñ¢, Precision Imaging Network, and Microsoft Cloud for Healthcare are collaborating to improve healthcare workflows using AI.  The webinar will cover AI models and their applications in stroke and cardiology.

Key Points:

‚Ä¢ AI-powered workflows improve efficiency in healthcare.

‚Ä¢ The webinar highlights the integration of multiple technologies.

‚Ä¢  48+ AI models for various medical specialties will be discussed.


üîó Resources:

‚Ä¢ [Viz.ai Webinar](http://Viz.ai) -  AI-powered healthcare workflows

![Image](https://pbs.twimg.com/media/GkQcEsxXcAAg5p2?format=jpg&name=small)


---
### üí° Rare Disease Day - Broad Institute Event

This article announces a speaker event at the Broad Institute for Rare Disease Day.  The speaker's son will be nearby, providing a personal connection to the event.

Key Points:

‚Ä¢  Event focuses on rare diseases.

‚Ä¢ The event is held at the Broad Institute.


üîó Resources:

![Image](https://pbs.twimg.com/media/GkQO9VyXkAEsYjd?format=jpg&name=small)


---
### ü§ñ Oncology Care - Patient-Reported Outcomes (PROs)

This article discusses the transformative potential of patient-reported outcomes (PROs) in oncology and the role of AI in improving their adoption.

Key Points:

‚Ä¢ PROs can significantly improve oncology care.

‚Ä¢ AI platforms facilitate wider adoption of PROs.

‚Ä¢ AI improves the standardization of PROs.


---
### ü§ñ Cardiovascular & Pulmonary Care - Butterfly iQ+ POCUS

This article summarizes research showcasing the efficiency gains from using Butterfly iQ+ point-of-care ultrasound (POCUS) in cardiovascular and pulmonary care.

Key Points:

‚Ä¢ Butterfly iQ+ POCUS streamlines cardiovascular and pulmonary care.

‚Ä¢  Cost reduction of 50% was observed.

‚Ä¢  Reduced hospital stays were reported.


üîó Resources:

‚Ä¢ [Becker's Article](https://bit.ly/3Q4asG3) -  Research on Butterfly iQ+ POCUS


---
### ‚ú® DeHealth - New Brand Ambassador

This article announces Alina Ponomarenko, Miss Ukraine and Miss World contestant, as a new brand ambassador for DeHealth.

Key Points:

‚Ä¢ DeHealth welcomes a new brand ambassador.

‚Ä¢ Alina Ponomarenko will represent DeHealth.


üîó Resources:

![Image](https://pbs.twimg.com/media/GkQK4PpWUAAR9f6?format=jpg&name=small)


---
### ü§ñ Precision Medicine in Prostate Cancer - ASCO GU25

This article summarizes the ArteraAI team's experience at the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium 2025 (#GU25).

Key Points:

‚Ä¢ ArteraAI shared insights on precision medicine.

‚Ä¢ The event focused on prostate cancer.

‚Ä¢  The team connected with colleagues in the field.


üîó Resources:

![Image](https://pbs.twimg.com/media/GkQF25gXYAEiXY6?format=jpg&name=360x360)
![Image](https://pbs.twimg.com/media/GkQF3EJW8AA8d8O?format=jpg&name=360x360)
![Image](https://pbs.twimg.com/media/GkQF3N4XEAAg5PG?format=jpg&name=360x360)
![Image](https://pbs.twimg.com/media/GkQF3X_XkAA940S?format=jpg&name=360x360)


---
### ü§ñ Colon Cancer Research - HMGA1 Epigenetic Regulator

This article highlights research identifying HMGA1 as a key driver in colon cancer development, suggesting potential new therapeutic strategies.

Key Points:

‚Ä¢ HMGA1 is identified as a key driver in colon cancer.

‚Ä¢ Targeting HMGA1 offers potential therapeutic strategies.

‚Ä¢ Research published in the Journal of Clinical Investigation.


üîó Resources:

‚Ä¢ [Journal of Clinical Investigation](https://doi.org/g85p4z) - Research on HMGA1 in colon cancer


---
### ‚ú® Polaris - Small Molecule Steering Committee

This article announces the addition of new members to Polaris's Small Molecule Steering Committee.

Key Points:

‚Ä¢ Polaris welcomes new members to its steering committee.

‚Ä¢ The committee focuses on small molecule development.


üîó Resources:

![Image](https://pbs.twimg.com/media/GkP_Y7gXkAI-2XG?format=jpg&name=small)


---
### üí° Oncology Treatment - Tempus Tumor + Normal Matched Approach

This article briefly discusses a tumor + normal matched approach in tailoring oncology treatment decisions based on patient-specific alterations.

Key Points:

‚Ä¢ Tumor + normal matched approach tailors treatment decisions.

‚Ä¢ Considers both tumor-driven and inherited alterations.


üîó Resources:

‚Ä¢ [Tempus](https://tempus.co/4gPlI44) - Information on the matched approach

![Image](https://pbs.twimg.com/ext_tw_video_thumb/1892319207406129152/pu/img/0OjQDHQ9y5wUlfLo.jpg)


---
### ü§ñ Healthcare Innovation - Viz.ai CEO Interview

This article announces a video interview with Viz.ai CEO Chris Mansi discussing challenges shaping the future of healthcare.

Key Points:

‚Ä¢  Interview with Viz.ai CEO Chris Mansi.

‚Ä¢  Focuses on challenges in healthcare's future.


üîó Resources:

‚Ä¢ [NYSE Interview](https://nyse.com/insights/the-cureious?t=34#future-of-healthcare-part-two) - Viz.ai CEO interview


---

### ‚≠êÔ∏è Support

If you liked reading this report, please star ‚≠êÔ∏è this repository and follow me on [Github](https://github.com/Drix10), [ùïè (previously known as Twitter)](https://x.com/DRIX_10_) to help others discover these resources and regular updates.

---